Results 161 to 170 of about 34,408 (196)
Pacritinib inhibits proliferation of primary effusion lymphoma cells and production of viral interleukin-6 induced cytokines. [PDF]
Wu Y, Wang V, Yarchoan R.
europepmc +1 more source
Circulating miRNA-375 as a potential novel biomarker for active Kaposi’s sarcoma in AIDS Patients [PDF]
Adriana Mattiolo +7 more
core +1 more source
5-AZA Upregulates SOCS3 and PTPN6/SHP1, Inhibiting STAT3 and Potentiating the Effects of AG490 against Primary Effusion Lymphoma Cells. [PDF]
Di Crosta M +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Daratumumab in Primary Effusion Lymphoma
New England Journal of Medicine, 2018Daratumumab in Primary Effusion Lymphoma In primary effusion lymphoma, a herpesvirus 8 (HHV-8)–associated neoplasm that is most common in HIV-coinfected patients, cells often express CD38.
Nirav N Shah, Arun K Singavi
exaly +2 more sources
Primary Effusion Lymphoma/Extracavitary Effusion Lymphoma
Pathology Case Reviews, 2012AbstractPrimary effusion lymphoma (PEL), and its solid counterpart, extracavitary PEL, is a rare, but unique, clinicopathologic entity, which is pathogenetically related to infection with the gamma herpesvirus, Kaposi sarcoma herpesvirus/human herpes virus 8.
Amy Lo, Amy Chadburn
openaire +1 more source
Current Opinion in Pulmonary Medicine, 2017
To summarize the current epidemiology, management, and outcomes of primary effusion lymphoma (PEL) and highlight possible future research efforts.Cyclophosphamide, doxorubicin, vincristine, prednisone-based chemotherapy regimens alone or in combination with immunomodulatory agents (e.g., lenalidomide), or proteasome inhibitors (e.g., bortezomib), or ...
Nivedita, Arora +2 more
openaire +2 more sources
To summarize the current epidemiology, management, and outcomes of primary effusion lymphoma (PEL) and highlight possible future research efforts.Cyclophosphamide, doxorubicin, vincristine, prednisone-based chemotherapy regimens alone or in combination with immunomodulatory agents (e.g., lenalidomide), or proteasome inhibitors (e.g., bortezomib), or ...
Nivedita, Arora +2 more
openaire +2 more sources
Extracavitary Primary Effusion Lymphoma of the Anorectum
Clinical Lymphoma and Myeloma, 2005We report a case of an extracavitary primary effusion lymphoma occurring in the anorectum of a patient with advanced acquired immune deficiency syndrome. The morphology, null cell immunophenotype, and acquisition of plasma cell markers in this case are typical of the so-called solid variant of primary effusion lymphoma. Lymphoma cells in this case were
Liron, Pantanowitz +3 more
openaire +2 more sources
Plasmablastic Lymphoma and Primary Effusion Lymphoma
2019Plasmablastic lymphoma (PBL) and primary effusion lymphoma (PEL) are rare CD20-negative variants of diffuse large B-cell lymphoma. Both conditions were initially described in patients with underlying HIV infection, but cases of PBL and PEL have been more recently diagnosed in other immunocompromised states and in immunocompetent individuals.
Thomas A. Guerrero-Garcia +1 more
openaire +1 more source
Pleural effusion as the presentation for primary effusion lymphoma
Surgery, 1998H N, Vu +4 more
openaire +2 more sources

